Mathematical optimisation of the cisplatin plus etoposide combination for managing extensive-stage small-cell lung cancer patients
Crossref DOI link: https://doi.org/10.1038/bjc.2016.439
Published Online: 2017-01-12
Published Print: 2017-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Faivre, C
El Cheikh, R
Barbolosi, D
Barlesi, F
Text and Data Mining valid from 2017-01-01
Article History
Revised: 19 November 2016
Accepted: 1 December 2016
First Online: 12 January 2017
Competing interests
: The authors declare no conflict of interest.